» Articles » PMID: 27175599

The Chronological Sequence of Somatic Mutations in Early Gastric Carcinogenesis Inferred from Multiregion Sequencing of Gastric Adenomas

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 May 14
PMID 27175599
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Mutation profiles and intratumoral heterogeneity are not well understood for benign gastric adenomas, some of which progress into malignant gastric adenocarcinomas. In this study, we performed whole-exome sequencing of three microsatellite stable (MSS) and two microsatellite instability-high (MSI-H) gastric adenomas with three regional tumor biopsies per case. We observed that the mutation abundance of benign gastric adenomas was comparable to those of gastric adenocarcinomas, suggesting that the mutational makeup for gastric carcinogenesis may already be achieved in benign adenomas. The extent of intratumoral heterogeneity was more substantial for MSS genomes in that only 1% - 14% of somatic mutations were common across the regional biopsies or 'public', while 50% - 94% of mutations were public in MSI-H gastric adenomas. We observed biallelic, loss-of-functional events of APC with truncating mutations and/or 5q losses for all cases, mostly as public events. All MSS gastric adenomas also harbored ARID2 truncating mutations, often as multiple, region-specific ones indicative of convergent evolution. Hotspot missense mutations on known cancer genes such as ERBB2 and KRAS were largely observed as region-specific aberrations. These findings suggest that biallelic functional APC inactivation initiates the gastric carcinogenesis and is followed by mutations of histone modifiers and then activation of known cancer-related genes. As the first exome-wide multi-region mutational profiling of gastric adenomas, our study provides clues on the chronological sequence of somatic mutations and their clonal architectures in early gastric carcinogenesis.

Citing Articles

Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.

Leung M, Swanton C, McGranahan N Nat Rev Genet. 2025; .

PMID: 40065153 DOI: 10.1038/s41576-025-00825-2.


Mutational signatures in 175 Chinese gastric cancer patients.

Liu F, Hu N, Jiang K, Liu H, Wang M, Hu Y BMC Cancer. 2024; 24(1):1208.

PMID: 39350044 PMC: 11440915. DOI: 10.1186/s12885-024-12968-2.


Comparative genomic landscape of lower-grade glioma and glioblastoma.

Sun X, Jia Q, Li K, Tian C, Yi L, Yan L PLoS One. 2024; 19(8):e0309536.

PMID: 39208202 PMC: 11361568. DOI: 10.1371/journal.pone.0309536.


Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair.

Ooki A, Osumi H, Yoshino K, Yamaguchi K Gastric Cancer. 2024; 27(5):907-931.

PMID: 38922524 PMC: 11335850. DOI: 10.1007/s10120-024-01523-4.


Whole-exome sequencing identifies cancer-associated variants of the endo-lysosomal ion transport channels in the Saudi population.

Binobaid L, As Sobeai H, Alhazzani K, AlAbdi L, Alwazae M, Alotaibi M Saudi Pharm J. 2024; 32(3):101961.

PMID: 38313820 PMC: 10832475. DOI: 10.1016/j.jsps.2024.101961.


References
1.
Knudson Jr A . Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971; 68(4):820-3. PMC: 389051. DOI: 10.1073/pnas.68.4.820. View

2.
Forbes S, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H . COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2014; 43(Database issue):D805-11. PMC: 4383913. DOI: 10.1093/nar/gku1075. View

3.
Yates L, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P . Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med. 2015; 21(7):751-9. PMC: 4500826. DOI: 10.1038/nm.3886. View

4.
Kim T, Jung S, An C, Lee S, Baek I, Kim M . Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity. Clin Cancer Res. 2015; 21(19):4461-72. DOI: 10.1158/1078-0432.CCR-14-2413. View

5.
Li M, Zhao H, Zhang X, Wood L, Anders R, Choti M . Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 2011; 43(9):828-9. PMC: 3163746. DOI: 10.1038/ng.903. View